Gene · 5921
Papers3,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of Cas13d as a tool for genetic interaction mapping. | Nat Commun | 2025 | 39952934 | PubTator, text mining | PubMed |
| The C2 domain augments Ras GTPase-activating protein catalytic activity. | Proc Natl Acad Sci U S A | 2025 | 39899710 | PubTator, text mining | PubMed |
| CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. | Oncogene | 2025 | 39890967 | PubTator, text mining | PubMed |
| Biallelic postzygotic RASA1 variants in a germline-negative patient with capillary malformation-arteriovenous malformation. | Int J Dermatol | 2025 | 39749805 | PubTator, text mining | PubMed |
| The significance of exosomal non-coding RNAs (ncRNAs) in the metastasis of colorectal cancer and development of therapy resistance. | Gene | 2025 | 39643147 | PubTator, text mining | PubMed |
| Variations in RASA1 and EPHB4 in Chinese patients with capillary malformation-arteriovenous malformation. | J Dermatol | 2025 | 39578666 | PubTator, text mining | PubMed |
| Second Report of the p.Leu874Pro Missense Variant in EPHB4 in a Family With Capillary Malformation-Arteriovenous Malformation Syndrome (CM-AVM) Syndrome. | Am J Med Genet A | 2025 | 39431828 | PubTator, text mining | PubMed |
| Genotypes and phenotypes of capillary malformation-arteriovenous malformation: characterization and correlation analysis. | Int J Dermatol | 2025 | 39367533 | PubTator, text mining | PubMed |
| 5q14.3 Microdeletion Syndrome With Simultaneous Involvement of MEF2C and RASA1. Clinical Case and Review of the Literature. | Pediatr Dermatol | 2025 | 39258307 | PubTator, text mining | PubMed |
| Cerebrovascular Anomalies in the Fetus. | AJNR Am J Neuroradiol | 2025 | 38866434 | PubTator, text mining | PubMed |
| LncRNA XIST Protects Against Polycystic Ovary Syndrome via the Regulation of miR-212-3p/RASA1 Axis. | Biochem Genet | 2025 | 38609670 | PubTator, text mining | PubMed |
| Ayurvedic Approaches to Holistic Management of Polycystic Ovary Syndrome (PCOS). | J Pharm Bioallied Sci | 2024 | 39926802 | PubTator, text mining | PubMed |
| Trace element and radiological characterisation of ash and soil at a legacy site in the former Raša coal-mining area. | Arh Hig Rada Toksikol | 2024 | 39718088 | PubTator, text mining | PubMed |
| Intravascular large B-cell lymphoma arising in the pituitary gland: A case report. | Medicine (Baltimore) | 2024 | 39686426 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from creeping fat stem cells promote lymphatic function and restrain inflammation of Crohn's disease. | Clin Transl Med | 2024 | 39623906 | PubTator, text mining | PubMed |
| Novel postzygotic RASA1 mutation in a patient with Parkes Weber syndrome: A case report and literature review. | Clin Case Rep | 2024 | 39498435 | PubTator, text mining | PubMed |
| EPHB4-RASA1 Inhibition of PIEZO1 Ras Activation Drives Lymphatic Valvulogenesis. | Circ Res | 2024 | 39421925 | PubTator, text mining | PubMed |
| DAB2IP loss in luminal a breast cancer leads to NF-κB-associated aggressive oncogenic phenotypes. | JCI Insight | 2024 | 39418101 | PubTator, text mining | PubMed |
| Current trends, molecular insights, and future directions toward precision medicine in the management of pediatric cerebral arteriovenous malformations. | J Neurosurg Pediatr | 2024 | 39241253 | PubTator, text mining | PubMed |
| An Atypical Mechanism of SUMOylation of Neurofibromin SecPH Domain Provides New Insights into SUMOylation Site Selection. | J Mol Biol | 2024 | 39216515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5921/papers?page=6